Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (26459)
All Articles published online
|
Publishing Process of This Article
|
Aug 10, 2014 (publication date) through Aug 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
2024 | Number of total visits
| Rank | Countries/Territories | Count | Percent |
| 1 | United States | 156 | 28% |
| 2 | China | 78 | 14% |
| 3 | Philippines | 60 | 10.8% |
| 4 | India | 27 | 4.8% |
| 5 | United Kingdom | 26 | 4.7% |
| 6 | Taiwan | 22 | 3.9% |
| 7 | Germany | 19 | 3.4% |
| 8 | Indonesia | 14 | 2.5% |
| 9 | Italy | 14 | 2.5% |
| 10 | Malaysia | 13 | 2.3% |
| 11 | Poland | 11 | 2% |
| 12 | Portugal | 10 | 1.8% |
| 13 | Ecuador | 8 | 1.4% |
| 14 | Australia | 7 | 1.3% |
| 15 | Korea, Republic of | 7 | 1.3% |
| 16 | Japan | 6 | 1.1% |
| 17 | Brazil | 6 | 1.1% |
| 18 | Canada | 6 | 1.1% |
| 19 | Ukraine | 6 | 1.1% |
| 20 | Colombia | 5 | 0.9% |
| 21 | Mexico | 5 | 0.9% |
| 22 | South Africa | 5 | 0.9% |
| 23 | Sweden | 5 | 0.9% |
| 24 | New Zealand | 4 | 0.7% |
| 25 | Iran, Islamic Republic of | 4 | 0.7% |
| 26 | Ghana | 3 | 0.5% |
| 27 | Switzerland | 3 | 0.5% |
| 28 | Spain | 3 | 0.5% |
| 29 | Netherlands | 3 | 0.5% |
| 30 | Singapore | 3 | 0.5% |
| 31 | Turkey | 3 | 0.5% |
| 32 | Morocco | 2 | 0.4% |
| 33 | Russia | 2 | 0.4% |
| 34 | Saudi Arabia | 2 | 0.4% |
| 35 | Argentina | 2 | 0.4% |
| 36 | Iceland | 1 | 0.2% |
| 37 | Cyprus | 1 | 0.2% |
| 38 | France | 1 | 0.2% |
| 39 | Austria | 1 | 0.2% |
| 40 | Norway | 1 | 0.2% |
| 41 | Pakistan | 1 | 0.2% |
| 42 | Mongolia | 1 | 0.2% |
| 43 | Qatar | 1 | 0.2% |